Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05985785 · ClinicalTrials.gov registry record · NA

Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection

A NA study of Osteoarthritis of the Knee, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05985785 is a NA study of Osteoarthritis of the Knee that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 100 participants, below the 215-participant average among 15 other Osteoarthritis of the Knee trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05985785, a NA study of Osteoarthritis of the Knee, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Prospective single-masked (study participant will be masked), randomized controlled trial to examine the influence of BMAC on patient-reported outcomes (PROs) in patients with primary knee osteoarthritis.

Conditions Studied

Interventions

  • OTHER Autologous bone marrow aspirate concentrate (BMAC)
  • DRUG Corticosteroid injections
  • OTHER Crossover Autologous bone marrow aspirate concentrate (BMAC)

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-07-19
Est. Completion 2028-03-31
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT05985785

The ClinicalTrials.gov registry entry for NCT05985785 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 215-participant average among 15 other Osteoarthritis of the Knee trials with a reported enrollment target (53% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoarthritis of the Knee appearing as the primary indexed condition, and to 3 interventions - of which Autologous bone marrow aspirate concentrate (BMAC) is the first listed.

NCT05985785 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05985785 about?

NCT05985785 is a clinical study titled "Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection". Prospective single-masked (study participant will be masked), randomized controlled trial to examine the influence of BMAC on patient-reported outcomes (PROs) in patients with primary knee osteoarthritis.

What is the current status of trial NCT05985785?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-07-19. Estimated completion is 2028-03-31.

What conditions does trial NCT05985785 study?

This clinical trial studies the following conditions: Osteoarthritis of the Knee.

What interventions are being tested in trial NCT05985785?

The interventions under investigation include: Autologous bone marrow aspirate concentrate (BMAC) (OTHER), Corticosteroid injections (DRUG), Crossover Autologous bone marrow aspirate concentrate (BMAC) (OTHER).

Who is sponsoring clinical trial NCT05985785?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05985785 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis of the Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.